These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 6215652)

  • 1. D-Fenfluramine and D-norfenfluramine reduce food intake by acting on different serotonin mechanisms in the rat brain.
    Borsini F; Bendotti C; Aleotti A; Samanin R; Garattini S
    Pharmacol Res Commun; 1982 Jul; 14(7):671-8. PubMed ID: 6215652
    [No Abstract]   [Full Text] [Related]  

  • 2. d-Fenfluramine and salbutamol: two drugs causing anorexia through different neurochemical mechanisms.
    Garattini S; Samanin R
    Int J Obes; 1984; 8 Suppl 1():151-7. PubMed ID: 6534892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is receptor activation involved in the mechanism by which (+)-fenfluramine and (+)-norfenfluramine deplete 5-hydroxytryptamine in the rat brain?
    Invernizzi R; Kmieciak-Kolada K; Samanin R
    Br J Pharmacol; 1982 Mar; 75(3):525-30. PubMed ID: 6175368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences between d-fenfluramine and d-norfenfluramine in serotonin presynaptic mechanisms.
    Borroni E; Ceci A; Garattini S; Mennini T
    J Neurochem; 1983 Mar; 40(3):891-3. PubMed ID: 6827286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of serotonin antagonists on the performance of a simple food acquisition task in rats treated with fenfluramine isomers.
    Thurlby PL; Garattini S; Samanin R
    Pharmacol Res Commun; 1985 Dec; 17(12):1129-39. PubMed ID: 4095123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fenfluramine and 5-hydroxytryptamine. Part 2: Involvement of brain 5-hydroxytryptamine in the anorectic activity of fenfluramine.
    Duhault J; Boulanger M; Voisin C; Malen C; Schmitt H
    Arzneimittelforschung; 1975 Nov; 25(11):1758-62. PubMed ID: 128366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on the role of 5-HT receptors in satiation and the effect of d-fenfluramine in the runway test.
    Neill JC; Bendotti C; Samanin R
    Eur J Pharmacol; 1990 Nov; 190(1-2):105-12. PubMed ID: 2127571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence that hypophagia induced by d-fenfluramine and d-norfenfluramine in the rat is mediated by 5-HT2C receptors.
    Vickers SP; Dourish CT; Kennett GA
    Neuropharmacology; 2001 Aug; 41(2):200-9. PubMed ID: 11489456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of fenfluramine and norfenfluramine stereoisomers on stimulant effects of d-amphetamine and apomorphine in the rat.
    Bendotti C; Borsini F; Zanini MG; Samanin R; Garattini S
    Pharmacol Res Commun; 1980 Jun; 12(6):567-74. PubMed ID: 7190710
    [No Abstract]   [Full Text] [Related]  

  • 10. d-Fenfluramine and d-norfenfluramine hypophagias do not require increased hypothalamic 5-hydroxytryptamine release.
    Oluyomi AO; Gibson EL; Barnfield AM; Curzon G
    Eur J Pharmacol; 1994 Oct; 264(1):111-5. PubMed ID: 7828639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A review of the CNS effects of fenfluramine, 780SE and norfenfluramine on animals and man.
    Reuter CJ
    Postgrad Med J; 1975; 51 Suppl 1():18-27. PubMed ID: 768966
    [No Abstract]   [Full Text] [Related]  

  • 12. Does fenfluramine act via norfenfluramine?
    Broekkamp CL; Weemaes AJ; Van Rossum JM
    J Pharm Pharmacol; 1975 Feb; 27(2):129-30. PubMed ID: 237073
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of fenfluramine and norfenfluramine on brain serotonin metabolism in rats.
    Fuller RW; Snoddy HD; Hemrick SK
    Proc Soc Exp Biol Med; 1978 Feb; 157(2):202-5. PubMed ID: 622385
    [No Abstract]   [Full Text] [Related]  

  • 14. The role of d-norfenfluramine in the indole-depleting effect of d-fenfluramine in the rat.
    Caccia S; Anelli M; Ferrarese A; Fracasso C; Garattini S
    Eur J Pharmacol; 1993 Mar; 233(1):71-7. PubMed ID: 7682511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of behavioral activity by norfenfluramine and related drugs in rats is not mediated by serotonin release.
    Callaway CW; Wing LL; Nichols DE; Geyer MA
    Psychopharmacology (Berl); 1993; 111(2):169-78. PubMed ID: 7870948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence that central 5-HT2 receptors do not play an important role in the anorectic activity of D-fenfluramine in the rat.
    Samanin R; Mennini T; Bendotti C; Barone D; Caccia S; Garattini S
    Neuropharmacology; 1989 May; 28(5):465-9. PubMed ID: 2566947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of the anorectic agent, d-fenfluramine, and its primary metabolite, d-norfenfluramine, on intact human platelet serotonin uptake and efflux.
    Johnson GJ; Leis LA; Dunlop PC; Weir EK
    J Thromb Haemost; 2003 Dec; 1(12):2663-8. PubMed ID: 14675103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased accumulation of brain 5-hydroxytryptophan after decarboxylase inhibition in rats treated with fenfluramine, norfenfluramine or p-chloroamphetamine.
    Fuller RW; Perry KW
    J Pharm Pharmacol; 1983 Sep; 35(9):597-8. PubMed ID: 6138413
    [No Abstract]   [Full Text] [Related]  

  • 19. Serotonin and the pharmacology of eating disorders.
    Samanin R; Garattini S
    Ann N Y Acad Sci; 1989; 575():194-207; discussion 207-8. PubMed ID: 2483797
    [No Abstract]   [Full Text] [Related]  

  • 20. Tolerance to fenfluramine anorexia: fact or fiction?
    Rowland NE; Carlton J
    Appetite; 1986; 7 Suppl():71-83. PubMed ID: 2427024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.